STOCK TITAN

Suzano S.A. (SUZ) Financials

SUZ NYSE
FY2025 annual
Revenue $9.2B +19.4% YoY
Net Income $2.4B n/m YoY
EPS (Diluted) $1.97 n/m YoY
Free Cash Flow $2.5B +34.3% YoY
Market Cap $11.4B as of Oct 29, 2026
Price / Sales 1.2x on $9.2B revenue, FY2025
Price / Earnings 4.6x on $2.4B net income, FY2025
Price / Book 1.4x on $8.0B equity, Q4 FY2025

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 29, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (20-F/6-K) Latest period FY2025, ended Dec 31, 2025 Reported Currency USD FYE December

Newest figures come from the 20-F for FY2025, filed Mar 24, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the SUZ SEC filings page.

Suzano S.A. (SUZ) reported $9.2B in revenue for fiscal year 2025, up 19.4% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 10 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 64 / 100
Financial Health Score 64/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Suzano S.A.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
84

Suzano S.A. has an operating margin of 21.3%, meaning the company retains $21 of operating profit per $100 of revenue. This strong profitability earns a score of 84/100, reflecting efficient cost management and pricing power. This is down from 33.1% the prior year.

Growth
52

Suzano S.A.'s revenue surged 19.4% year-over-year to $9.2B, reflecting rapid business expansion. This strong growth earns a score of 52/100.

Leverage
17

Suzano S.A. has elevated debt relative to equity (D/E of 2.10), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 17/100, reflecting increased financial risk.

Liquidity
81

With a current ratio of 3.19, Suzano S.A. holds $3.19 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 81/100.

Cash Flow
89

Suzano S.A. converts 27.1% of revenue into free cash flow ($2.5B). This strong cash generation earns a score of 89/100.

Returns
62

Suzano S.A.'s ROE of 30.6% shows moderate profitability relative to equity, earning a score of 62/100. This is up from -21.9% the prior year.

Piotroski F-Score Strong
8/9

Suzano S.A. passes 8 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), all 3 leverage/liquidity signals pass, 1 of 2 operating efficiency signals passes.

Earnings Quality Cash-Backed
1.35x

For every $1 of reported earnings, Suzano S.A. generates $1.35 in operating cash flow ($3.3B OCF vs $2.4B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage At Risk
1.88x

Suzano S.A. earns $1.88 in operating income for every $1 of interest expense ($1.9B vs $1.0B). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$2.4B
YoY+4.4%
QoQ+4.9%

Suzano S.A. generated $2.4B in revenue in Q4 2025. This represents an increase of 4.4% from the same quarter a year earlier. Against the prior quarter it is up 4.9%.

EBITDA
$1.2B
YoY+3.1%
QoQ+33.3%

Suzano S.A.'s EBITDA was $1.2B in Q4 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 3.1% from the same quarter a year earlier. Against the prior quarter it is up 33.3%.

Net Income
$19.9M
YoYn/m
QoQ-94.6%

Suzano S.A. reported $19.9M in net income in Q4 2025. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. Against the prior quarter it is down 94.6%.

EPS (Diluted)
$0.02
YoYn/m
QoQ-94.4%

Suzano S.A. earned $0.02 per diluted share (EPS) in Q4 2025. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. Against the prior quarter it is down 94.4%.

Cash & Balance Sheet

Free Cash Flow
$767.8M
YoY+13.4%
QoQ+26.7%

Suzano S.A. generated $767.8M in free cash flow in Q4 2025, representing cash available after capex. This represents an increase of 13.4% from the same quarter a year earlier. Against the prior quarter it is up 26.7%.

Cash & Debt
$2.8B
YoY+90.0%
QoQ-6.8%
5Y CAGR+16.1%

Suzano S.A. held $2.8B in cash against $16.8B in long-term debt as of Q4 2025.

Shares Outstanding
1.26B
YoY0.0%
QoQ0.0%

Suzano S.A. had 1.26B shares outstanding in Q4 2025. That is unchanged from the same quarter a year earlier. It is unchanged from the prior quarter.

Dividends Per Share

Not reported for Q4 2025.

Margins & Returns

Gross Margin
30.6%
YoY-7.6pp
QoQ+0.2pp

Suzano S.A.'s gross margin was 30.6% in Q4 2025, indicating the percentage of revenue retained after direct costs. This is down 7.6 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.2 percentage points.

Operating Margin
27.0%
YoY-4.1pp
QoQ+10.8pp

Suzano S.A.'s operating margin was 27.0% in Q4 2025, reflecting core business profitability. This is down 4.1 percentage points from the same quarter a year earlier. Against the prior quarter it is up 10.8 percentage points.

Net Margin
0.8%
YoY+48.4pp
QoQ-15.2pp

Suzano S.A.'s net profit margin was 0.8% in Q4 2025, showing the share of revenue converted to profit. This is up 48.4 percentage points from the same quarter a year earlier. Against the prior quarter it is down 15.2 percentage points.

Return on Equity
0.3%
YoY+21.1pp
QoQ-4.1pp

Suzano S.A.'s quarterly ROE was 0.3% in Q4 2025: one quarter's net income over shareholder equity, not annualized. This is up 21.1 percentage points from the same quarter a year earlier. Against the prior quarter it is down 4.1 percentage points.

Capital Allocation

Capital Expenditures
$210.7M
YoY-35.3%
QoQ+39.3%

Suzano S.A. invested $210.7M in capex in Q4 2025, funding long-term assets and infrastructure. This represents a decrease of 35.3% from the same quarter a year earlier. Against the prior quarter it is up 39.3%.

R&D Spending

Not reported for Q4 2025.

Share Buybacks

Not reported for Q4 2025.

SUZ Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

SUZ quarterly income statement
MetricQ4'2520-FQ3'256-KQ2'256-KQ1'256-KQ4'2420-FQ3'246-KQ2'246-KQ1'246-K
Revenue$2.4B+4.4%$2.3B+1.3%$2.4B+18.4%$2.0B+6.7%$2.3B$2.3B$2.1B+8.6%$1.9B
Cost of Revenue$1.7B+17.3%$1.6B+26.3%$1.6B+44.7%$1.3B+18.5%$1.4B$1.3B$1.1B-15.4%$1.1B
Gross Profit$733.1M-16.3%$694.5M-30.2%$863.4M-11.1%$666.1M-11.1%$875.9M$995.4M$971.5M+59.4%$749.5M
Operating Income$647.3M-9.4%$369.7M-51.0%$529.6M-36.2%$393.5M-22.7%$714.1M$753.9M$829.9M+30.1%$508.9M
EBITDA$1.2B+3.1%$891.5M-23.2%$1.0B-13.3%$813.0M-8.4%$1.2B$1.2B$1.2B$887.6M
Interest Expense$162.3M+14.0%$342.3M+19.1%$295.9M+42.7%$236.9M+39.3%$142.4M$287.5M$207.4M-13.2%$170.1M
Income TaxN/AN/AN/A-$628.4M-545.2%N/AN/AN/A$141.1M
Net Income$19.9Mn/m$366.7M-38.0%$921.8Mn/m$1.1B+2471.9%-$1.1B$591.5M-$678.1M-164.3%$42.9M
EPS (Basic)$0.02n/m$0.30-37.2%$0.75n/m$0.89+2568.9%-$0.86$0.47-$0.53-165.1%$0.03
EPS (Diluted)$0.02n/m$0.30-37.2%$0.74n/m$0.89+2562.3%-$0.86$0.47-$0.53-165.1%$0.03
Diluted Shares (Avg)N/AN/AN/A1.24B-3.4%N/AN/AN/A1.29B

Not reported in any period shown, so not listed: R&D Expenses, SG&A Expenses.

SUZ Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

SUZ quarterly balance sheet
MetricQ4'2520-FQ3'256-KQ2'256-KQ1'256-KQ4'2420-FQ3'246-KQ2'246-KQ1'246-K
Total Assets$30.7B+14.3%$30.9B$29.4B+6.6%$27.0B$26.8B-9.3%N/A$27.5B-4.2%N/A
Current Assets$8.0B+17.4%$8.0B$7.4B+4.5%$6.0B$6.8B-14.2%N/A$7.0B-11.1%N/A
Cash & Equivalents$2.8B+90.0%$3.0B+178.6%$2.3B+73.6%$1.7B+106.1%$1.5B-15.2%$1.1B$1.3B-47.1%$838.1M
Inventory$1.5B+15.7%$1.7B$1.6B+23.8%$1.5B$1.3B+5.1%N/A$1.3B-4.0%N/A
Accounts Receivable$1.2B-18.9%$1.2B$1.3B+3.3%$1.1B$1.5B+4.6%N/A$1.3BN/A
Goodwill$5.4M-85.3%$35.6M$33.3M-19.0%$39.0M$36.5M-22.7%N/A$41.2M-15.1%N/A
Total Liabilities$22.6B+4.8%$22.4B$21.4B+5.7%$20.3B$21.6B+6.1%N/A$20.2B+1.8%N/A
Current Liabilities$2.5B-36.5%$2.5B$2.3B-18.0%$2.3B$4.0B+29.8%N/A$2.8B-8.2%N/A
Non-Current Liabilities$20.1B+14.1%$19.9B$19.1B+9.6%$18.0B$17.6B+1.9%N/A$17.4B+3.7%N/A
Long-Term Debt$16.8B+14.0%$16.7B$16.3B+11.7%$15.3B$14.7B-1.5%N/A$14.6B+2.0%N/A
Total Equity$8.0B+53.2%$8.5B+11.0%$7.9B+9.1%$6.7B-25.0%$5.2B-43.3%$7.6B$7.3B-17.7%$8.9B
Retained EarningsN/A$2.5B$2.1Bn/m$1.1BN/AN/A-$632.9M-129.4%N/A

Not reported in any period shown, so not listed: Short-Term Investments, Long-Term Investments.

SUZ Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

SUZ quarterly cash flow statement
MetricQ4'2520-FQ3'256-KQ2'256-KQ1'256-KQ4'2420-FQ3'246-KQ2'246-KQ1'246-K
Operating Cash Flow$978.6M-2.4%$757.3M-21.8%$799.5M-26.8%$769.6M+26.4%$1.0B$968.4M$1.1B$609.0M
Depreciation & Amortization$541.4M+23.3%$521.7M+28.3%$508.5M+38.3%$419.5M+10.8%$439.0M$406.7M$367.6M$378.7M
Capital Expenditures$210.7M-35.3%$151.3M-61.7%$255.4M-42.5%$214.6M-57.9%$325.7M$394.6M$444.1M$509.7M
Free Cash Flow$767.8M+13.4%$606.0M+5.6%$544.1M-16.0%$555.0M+459.0%$677.3M$573.8M$647.4M$99.3M
Investing Cash Flow-$918.0Mn/m-$614.3Mn/m-$894.6Mn/m$579.1Mn/m-$935.5M-$943.0M-$638.5M-$1.2B
Financing Cash Flow-$261.9M-167.0%$586.9Mn/m$568.6M+782.6%-$1.1Bn/m$390.8M-$287.8M$64.4M-$257.1M

Not reported in any period shown, so not listed: Stock-Based Compensation, Dividends Paid, Share Buybacks.

SUZ Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

SUZ quarterly financial ratios
MetricQ4'2520-FQ3'256-KQ2'256-KQ1'256-KQ4'2420-FQ3'246-KQ2'246-KQ1'246-K
Gross Margin30.6%-7.6pp30.4%-13.8pp35.3%-11.7pp33.1%-6.6pp38.2%44.2%47.0%+15.0pp39.7%
Operating Margin27.0%-4.1pp16.2%-17.3pp21.6%-18.5pp19.6%-7.4pp31.1%33.5%40.1%+6.6pp27.0%
Net Margin0.8%+48.4pp16.1%-10.2pp37.6%+70.4pp54.9%+52.6pp-47.6%26.3%-32.8%-88.2pp2.3%
Return on Equity0.3%+21.1pp4.3%-3.4pp11.6%+20.9pp16.5%+16.0pp-20.9%7.8%-9.3%-21.2pp0.5%
Return on Assets0.1%+4.1pp1.2%3.1%+5.6pp4.1%-4.1%N/A-2.5%-6.1ppN/A
Current Ratio3.19+1.5x3.203.16+0.7x2.611.72-0.9xN/A2.48-0.1xN/A
Debt-to-Equity2.10-0.7x1.982.060.0x2.282.82+1.2xN/A2.01+0.4xN/A
Liabilities-to-Equity2.83-1.3x2.642.69-0.1x3.044.14+1.9xN/A2.78+0.5xN/A
Asset Turnover0.080.0x0.070.080.0x0.070.09N/A0.080.0xN/A
FCF Margin32.1%+2.5pp26.6%+1.1pp22.2%-9.1pp27.6%+22.3pp29.5%25.5%31.3%5.3%

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company Fiscal year Revenue Net income Net margin Market cap Health score
Suzano S.A. SUZ FY2025 $9.2B $2.4B 26.8% $11.4B 64/100
Sylvamo Corporation SLVM FY2025 $3.4B $132.0M 3.9% $1.3B 48/100
Magnera Corporation MAGN FY2025 $3.2B -$159.0M -5.0% $430.0M 41/100
Sociedad Quimica y Minera de Chile SA SQM FY2025 $4.6B $640.6M 14.0% $16.1B 60/100
Westlake Corporation WLK FY2025 $11.2B -$1.5B -13.5% $8.4B 36/100
Cemex S.A.B. de C.V. CX FY2025 $16.1B $970.0M 6.0% $15.6B 50/100

Frequently Asked Questions

What is Suzano S.A.'s annual revenue?

Suzano S.A. (SUZ) reported $9.2B in total revenue for fiscal year 2025. This represents a 19.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Suzano S.A.'s revenue growing?

Suzano S.A. (SUZ) revenue grew by 19.4% year-over-year, from $7.7B to $9.2B in fiscal year 2025.

Is Suzano S.A. profitable?

Yes, Suzano S.A. (SUZ) reported a net income of $2.4B in fiscal year 2025, with a net profit margin of 26.8%.

Suzano S.A. (SUZ) reported diluted earnings per share of $1.97 for fiscal year 2025. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Suzano S.A. (SUZ) had EBITDA of $3.9B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2025, Suzano S.A. (SUZ) had $2.8B in cash and equivalents against $16.8B in long-term debt.

Suzano S.A. (SUZ) had a gross margin of 32.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Suzano S.A. (SUZ) had an operating margin of 21.3% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Suzano S.A. (SUZ) had a net profit margin of 26.8% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Suzano S.A. (SUZ) has a return on equity of 30.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Suzano S.A. (SUZ) generated $2.5B in free cash flow during fiscal year 2025. This represents a 34.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Suzano S.A. (SUZ) generated $3.3B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Suzano S.A. (SUZ) had $30.7B in total assets as of fiscal year 2025, including both current and long-term assets.

Suzano S.A. (SUZ) invested $836.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Suzano S.A. (SUZ) had 1.26B shares outstanding as of fiscal year 2025.

Suzano S.A. (SUZ) had a current ratio of 3.19 as of fiscal year 2025, which is generally considered healthy.

Suzano S.A. (SUZ) had a debt-to-equity ratio of 2.10 as of fiscal year 2025. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.

Suzano S.A. (SUZ) had a liabilities-to-equity ratio of 2.83 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.

Suzano S.A. (SUZ) had a return on assets of 8.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Suzano S.A. (SUZ) trades at 4.6x earnings, its market capitalization divided by $2.4B net income, FY2025. The market capitalization is $11.4B as of Oct 29, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Suzano S.A. (SUZ) trades at 1.2x sales, its market capitalization divided by $9.2B revenue, FY2025. The market capitalization is $11.4B as of Oct 29, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Suzano S.A. (SUZ) has a Piotroski F-Score of 8 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Suzano S.A. (SUZ) has an earnings quality ratio of 1.35x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Suzano S.A. (SUZ) has an interest coverage ratio of 1.88x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Suzano S.A. (SUZ) scores 64 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is the average of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top